Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial Evaluating Neoadjuvant Endocrine Therapy Combined With Chemotherapy in the Treatment of ER-positive, HER2-negative Stage I-III Breast Cancer

NCT07801898 is registered in ClinicalTrials.gov with The Second Hospital of Anhui Medical University as lead sponsor.

NCT NCT07801898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07801898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial Evaluating Neoadjuvant Endocrine Therapy Combined With Chemotherapy in the Treatment of ER-positive, HER2-negative Stage I-III Breast Cancer
Lead sponsor
The Second Hospital of Anhui Medical University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
March 30, 2029
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer (stage i-iii)